Is Annular Reduction the Answer to Tricuspid Regurgitation?
- PMID: 34317134
- PMCID: PMC8299970
- DOI: 10.1016/j.jaccas.2020.10.010
Is Annular Reduction the Answer to Tricuspid Regurgitation?
Keywords: 3-dimensional imaging; right ventricle; tricuspid valve; valve repair.
Conflict of interest statement
Dr. Dreyfus has held teaching courses for Edwards Lifesciences. Dr. Caussin has been a proctor for Edwards Lifesciences, Abbott Laboratories, Medtronic, and Boston Scientific. Dr. Dulguerov has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
References
-
- Enriquez-Sarano M., Messika-Zeitoun D., Topilsky Y. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62:447–451. - PubMed
-
- Topilsky Y., Maltais S., Medina Inojosa J. Burden of tricuspid regurgitation in patients diagnosed in the community setting. J Am Coll Cardiol Img. 2019;12:433–442. - PubMed
-
- Topilsky Y., Nkomo V.T., Vatury O. Clinical outcome of isolated tricuspid regurgitation. J Am Coll Cardiol Img. 2014;7:1185–1194.
-
- Benfari G., Antoine C., Miller W.L. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140:196–206. - PubMed
-
- Essayagh B., Antoine C., Benfari G. Functional tricuspid regurgitation of degenerative mitral disease: a crucial determinant of survival. Eur Heart J. 2020;41:1918–1929. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
